| TP53 |
TP53, P53: Cellular tumor antigen p53 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
36.060 |
Evidence |
|
| PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
SHB |
SHB: SH2 domain-containing adapter protein B |
33.250 |
Evidence |
O
|
| PCNA |
PCNA: Proliferating cell nuclear antigen |
FEN1 |
FEN1, RAD2: Flap endonuclease 1 |
32.960 |
Evidence |
O
|
| KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
32.910 |
Evidence |
|
| PDCD6IP |
PDCD6IP, AIP1, ALIX, KIAA1375: Programmed cell death 6-interacting protein |
CHMP4C |
CHMP4C, SHAX3: Charged multivesicular body protein 4c |
32.860 |
Evidence |
O
|
| PDCD6IP |
PDCD6IP, AIP1, ALIX, KIAA1375: Programmed cell death 6-interacting protein |
CHMP4B |
CHMP4B, C20orf178, SHAX1: Charged multivesicular body protein 4b |
32.860 |
Evidence |
O
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
CSF1R |
CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor |
32.710 |
Evidence |
O
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
PDGFRB |
PDGFRB: Beta-type platelet-derived growth factor receptor precursor |
32.710 |
Evidence |
O
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
KIT |
KIT: Mast/stem cell growth factor receptor precursor |
32.710 |
Evidence |
O
|
| CHMP1B |
CHMP1B, C18orf2: Charged multivesicular body protein 1b |
VPS4A |
VPS4A, VPS4: Vacuolar protein sorting-associating protein 4A |
32.2 |
Evidence |
|
| MAPK1 |
MAPK1, ERK2, PRKM1, PRKM2: Mitogen-activated protein kinase 1 |
MAP2K2 |
MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki |
31.770 |
Evidence |
O
|
| B2M |
B2M, CDABP0092, HDCMA22P: Beta-2-microglobulin precursor [Contains: Beta-2-micro |
LILRB1 |
IPI00385703 |
31.520 |
Evidence |
|
| CCNA2 |
CCNA2, CCN1, CCNA: Cyclin-A2 |
CDK2 |
CDK2: Cell division protein kinase 2 |
31.410 |
Evidence |
O
|
| RB1 |
RB1: Retinoblastoma-associated protein |
HDAC1 |
HDAC1, RPD3L1: Histone deacetylase 1 |
31.040 |
Evidence |
O
|
| RAC2 |
RAC2: Ras-related C3 botulinum toxin substrate 2 precursor |
ARHGDIA |
ARHGDIA, GDIA1: Rho GDP-dissociation inhibitor 1 |
31.000 |
Evidence |
O
|
| F2 |
F2: Prothrombin precursor |
THBD |
THBD, THRM: Thrombomodulin precursor |
29.770 |
Evidence |
O
|
| SOCS1 |
SOCS1, SSI1, TIP3: Suppressor of cytokine signaling 1 |
INSR |
INSR: Insulin receptor precursor |
29.300 |
Evidence |
|
| KHDRBS1 |
KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
28.920 |
Evidence |
|
| CDK2 |
CDK2: Cell division protein kinase 2 |
CKS1B |
CKS1B, CKS1, PNAS-16, PNAS-143: Cyclin-dependent kinases regulatory subunit 1 |
28.700 |
Evidence |
O
|
| MCM6 |
MCM6: DNA replication licensing factor MCM6 |
ORC6L |
ORC6L: Origin recognition complex subunit 6 |
28.2 |
Evidence |
O
|
| MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
ORC2L |
ORC2L, ORC2: Origin recognition complex subunit 2 |
28.2 |
Evidence |
O
|
| CDC6 |
CDC6, CDC18L: Cell division control protein 6 homolog |
ORC6L |
ORC6L: Origin recognition complex subunit 6 |
28.2 |
Evidence |
O
|
| MCM4 |
MCM4, CDC21: DNA replication licensing factor MCM4 |
ORC6L |
ORC6L: Origin recognition complex subunit 6 |
28.2 |
Evidence |
|
| MCM7 |
MCM7, CDC47, MCM2: DNA replication licensing factor MCM7 |
ORC6L |
ORC6L: Origin recognition complex subunit 6 |
28.2 |
Evidence |
|
| MCM2 |
MCM2, BM28, CCNL1, CDCL1, KIAA0030: DNA replication licensing factor MCM2 |
ORC6L |
ORC6L: Origin recognition complex subunit 6 |
28.2 |
Evidence |
O
|
